Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02056106Phase 4Completed
Phase 4, randomised, open-label trial of antidepressant (TDDS/ODF) in major depressive disorder (MDD) (2 arms), sponsored by RanD. Primary endpoints: Depression diagnostic evaluation at Month 12, Antidepressant prescription at Month 12 and 1 more. Started Jan 2013; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02056106.